University of Kentucky

UKnowledge
DNP Projects

College of Nursing

2022

The Effect of Education on the NIDA Modified Assist (NMASSIST)
Tool on Knowledge and Screening for Substance Use Disorder
among Clinicians
Victoria Page Arnold
University of Kentucky, victoria.arnold@uky.edu

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Arnold, Victoria Page, "The Effect of Education on the NIDA Modified Assist (NMASSIST) Tool on
Knowledge and Screening for Substance Use Disorder among Clinicians" (2022). DNP Projects. 393.
https://uknowledge.uky.edu/dnp_etds/393

This Practice Inquiry Project is brought to you for free and open access by the College of Nursing at UKnowledge. It
has been accepted for inclusion in DNP Projects by an authorized administrator of UKnowledge. For more
information, please contact UKnowledge@lsv.uky.edu.

The Effect of Education on the NIDA Modified Assist (NMASSIST) Tool on Knowledge and
Screening for Substance Use Disorder among Clinicians

Submitted in Practical Fulfillment of the Requirements for the Degree of Doctor of Nursing
Practice at the University of Kentucky

By
Victoria P. Arnold, BSN RN
Lexington, KY
2022

Abstract
Background: Substance use disorder (SUD) is a disparity affecting nearly 24 million
individuals in the U.S., nearly 10% of the total population. Oftentimes, the emergency
department (ED) is the only medical care this population receives. There is often a lack of
screening for SUD in ED’s, therefore referred care may be limited for these individuals. The
National Institute on Drug Abuse Modified Assist (NMASSIST) is an evidence-based tool
developed to educate and screen for SUD. This tool can be completed in a timely manner and
aid in the recommended referral of care for this select population.
Purpose: The purpose of this DNP project was to evaluate clinician knowledge regarding SUD
and screening ability in the adult population in an acute ED setting.
Methods: A pre/posttest design was utilized to examine changes in clinician knowledge and
ability to screen for SUD. An educational module was developed and administered to 15
registered nurses and 12 advanced practice providers/physicians. Clinicians completed a
pre/posttest questionnaire prior to and after reviewing the educational module as well as a
satisfaction survey.
Results: There was a statistically significant increase in clinician knowledge, comfortability,
and frequency of screening for SUD (p<0.001) after the implementation of the educational
module. Baseline knowledge increased by 87%, comfortability of screening for SUD increased
by 100%, and frequency of SUD screening showed an increase of nearly 37%. All clinicians that
partook in this project (100%) felt this module was useful, should be recommended to clinicians,
and felt the NMASSIST could be utilized in the ED setting.
Conclusion: Clinicians demonstrated an increase in knowledge of SUD, increase of screening,
and felt more comfortable screening after the implementation of this module.
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Background and Significance
Problem Statement
Substance use disorder (SUD) is defined as “the recurrent use of alcohol and/or drugs
causing clinically significant impairment, including health problems, disability and failure to
meet major responsibilities at work, school, or home” (Substance Abuse and Mental Health
Services Administration [SAMHSA], 2020, para. 4). SUD is a disparity affecting nearly 10% of
the United States (U.S.) adult population, with an estimated more than 24 million people
abusing illegal substances (National Institute on Drug Abuse [NIDA], 2015). Of this number,
more than 64,000 deaths occur yearly related to overdoses (NIDA, 2015). In 2018, there were an
estimated 53.2 million (19.4%) U.S. individuals who used illegal substances within the past year
(SAMHSA, 2019). In 2020, 59.3 million (21.4%) U.S. individuals used illicit drugs in the past
year (SAMHSA, 2021).
Context, Scope, and Consequences of SUD
In 2017, there were 70,237 deaths in the U.S. related to drug overdoses, and 967,615
nonfatal overdoses (Vivolo-Kantor et al., 2020). In 2020, the deaths related to drug overdoses
increased to an estimated 91,799 (NIDA, 2012). There is an increased incidence of people of
have overdoses on drugs that are seen in the emergency department (ED). According to Unick et
al. (2013), in 2000, approximately 40 in 100,000 ED visits were due to overdoses, and this
number doubled by 2010 (Unick et al., 2013). According to Vivolo-Kanter et al. (2018), in 2017
approximately 157 in 100,000 ED visits were due to overdoses.
The cost of SUD in the U.S. is estimated at over $193 billion annually, including acts of
crime, healthcare expenses, and rehabilitative services (Connors et al., 2013). Of the population
with SUD in 2015, a projected 22.7 million U.S. citizens required rehabilitation treatment;
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however, only 2.5 million received such treatment (NIDA, 2015). The number of overdoses
treated in the ED continue to rise by the thousands yearly. It is suggested that one in 20
individuals seen in the ED from a nonfatal overdose die within 1 year due to fatality from SUD
(NIDA, 2020). These statistics highlight the importance of linking those with SUD to treatment
resources.
Evidence-Based Intervention Targeting SUD
SUD holds no bias to age, health determinants, or socioeconomic standing. Screening,
detection, and awareness of SUD using the NIDA Modified Assist (NMASSIST) screening tool
is an evidence-based approach developed to address SUD in this population (NIDA, 2012). The
NMASSIST includes eight questions regarding SUD (desired use, use of substances, problems
associated with substance use) (Zgierska et al., 2014). This evidence-based tool is recommended
for clinician use to not only determine adults at risk for/suffering from SUD but in guiding them
to treatment options and referrals. The NMASSIST has been proven to be effective in alerting
clinicians to acute and long-term effects of SUD as well as withdrawal symptoms,
vulnerabilities in certain SUD populations (including youth, older adults, and pregnant women),
as well as treatment recommendations and referral (NIDA, 2012).
There are several available tools to screen for SUD in adults, such as the tobacco,
alcohol, prescription medication, and other substance use (TAPS) tool (NIDA, 2018). There are
also pediatric screening tools such as the screening to brief intervention (S2BI) tool (NIDA,
2017). However, the NMASSIST is a quick screening questionnaire that may be completed in a
more accessible and timely manner in an ED due to this tool solely focusing on illicit drug use in
adults, unlike other screening tools focusing on alcohol, tobacco, and illicit drug use.
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Screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based
practice developed to increase the proper diagnosis of SUD (Bernstein & D’Onofrio, 2013).
Utilizing the NMASSIST will allow patients to receive SBIRT, and will aid in the appropriate
treatment and referral recommendations. A pilot study among clinicians reported significant
improvements in knowledge, attitudes, confidence and capability related to SUD treatment
utilizing SBIRT versus no education (Osborne & Benner, 2012). According to Bernstein and
D’Onofrio (2013), when SBIRT and the NMASSIST are utilized in conjunction, research has
shown efficacy in this educational approach. Zgierska et al. (2014) recommend presenting case
studies as a means to familiarize oneself with the NMASSIST and Quick Screen guide (NIDA,
2012).
Purpose
The purpose of this DNP project was to evaluate clinician knowledge regarding
substance use disorder and screening ability in the adult population in an acute emergency
department setting.
Aims
The specific aims of this project include: 1) the assessment of baseline SUD knowledge
and screening practices, 2) the evaluation of SUD knowledge and screening practices post
intervention, and 3) satisfaction of educational intervention.
Theoretical Framework
The theoretical framework used to guide this DNP project was the Theory of Planned
Behavior (TPB) (Ajzen, 1991). The TPB examines relationships between one’s beliefs,
attitudes, intentions, behavior, and perceived control over such behavior (Ajzen, 1991; Connor,
2020). A focus of the TBP is the intent to perform a behavior, and to what extent one is willing
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to accomplish such behavior (Ajzen, 1991). For this DNP project, the NMASSIST education
focused on addressing clinician attitudes and perceived behavior control grounded on the
concepts of the TPB. Thus, by educating clinicians on the NMASSIST and the impact of SUD
on communities there should be an increased readiness to improve attitudes and perceived
behavioral control among clinicians. Theoretically, there should also be a corresponding
increase in their frequency and ability to screen and refer the SUD population.
Literature Review
To determine the evidence supporting the utilization of the NMASSIST tool in
enhancing ED clinicians’ knowledge and screening for SUD, a literature review was conducted.
Using the PICO format, a guiding question for the review was: Among emergency medical
clinicians, has the education of the NMASSIST tool enhanced clinician knowledge and
substance screening practices in the adult population? A literature review was conducted
utilizing PubMed, EBSCO, Google scholar, PsychINFO, and the University of Kentucky library
database. Results were based on the last 10 years of publication. Keyword search items
included: NIDA-modified ASSIST tool (elicited 15,200 results, limited to 8,490 within last 10
years of publication), and emergency department screening education substance abuse (elicited
228,000 results, limited to 18,800 within last 10 years of publication). Inclusion criteria included
randomized controlled trials, qualitative studies, peer-reviewed studies, and meta-analysis
reviews. Exclusion criteria included articles older than 10 years and articles published in any
language other than English. Approximately 11 articles met inclusion criteria and were selected
for inclusion.
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Synthesis of the Evidence
The U.S. Preventive Services Task Force (2020) recommends screening adults 18 years
and older for substance use. However, there are no screening or policy recommendations for
SUD other than alcohol for many ED’s (Hawk & D’Onofrio, 2018). SUD has often been
underdiagnosed and undertreated in the ED, in part due to lack of clinician knowledge
(Bernstein & D’Onofrio, 2013). The NIDA Quick Screen is a single substance use question
“how many times in the past year have you used an illegal drug or prescription medication for
nonmedical reasons” (NIDA, 2012), which can be easily used in the ED (Hawk & D’Onofrio,
2018). The NIDA quick screen was concluded to have 100% sensitivity and 73.5% specificity
for the recognition of SUD in primary care (Hawk & D’Onofrio, 2018). If this quick screen
question is answered yes, the clinician proceeds to implement the NMASSIST, as this is
intended to follow the NIDA quick screen (NIDA, 2012).
According to NIDA (2012), the NMASSIST is an evidenced-based substance use
screening tool adaptation from the SBIRT program recommended by SAMHSA (SAMHSA,
2022) utilized to identify adults at risk/suffering from SUD, as well as recommendations for
treatment based on individualized scores (see Figures 1 and 2). This tool was designed to
improve clinician knowledge, decision making and screening rates by its accessibility, ease of
use, information provided in regards to SUD, and treatment recommendations provided based
on scores as well as substances abused (NIDA, 2012). The NMASSIST was found to have the
highest percentages of sensitivity (54-97%) as well as specificity (50-96%) in five randomized
control trials (RCT) (Bernstein et al., 2005; Zahradnik et al., 2009; Humeniuk et al., 2012; Saitz
et al., 2010; Roy-Byrne et al., 2014), deeming it level 1 evidence (Zgierska et al., 2014). This
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tool’s proven efficacy, ease of usage, and timely completion ability justify why it was chosen for
implementation for this DNP project versus other tools.
Gaps in Practice
There are several gaps related to ED screening for SUD as well as limited evidence
available throughout extensive research. Hawk and D’Onofrio (2018) reported there are often no
screening tools implemented or recommended for SUD in ED’s. Some barriers may be due to
increased volume of patients, unknown availability of screening tools, focused care, lack of
time, high priority patients, stigma, as well as lack of staff (Hawk & D’Onofrio, 2018). This
DNP project educational intervention was expected to increase screening knowledge and ability
for SUD patients to receive SBIRT, and close the gap related to lack of SUD screening in the
ED.
Methods
Design
This DNP project utilized a one group pre/posttest design to examine the effect of a
PowerPoint educational module on alterations in clinicians’ assessment of baseline SUD
knowledge and screening practices.
Setting
Agency Description
The setting chosen for this project was Ephraim McDowell Regional Medical Center
Emergency Department, a regional-level three trauma center in rural Kentucky. This regional
facility is the largest of three hospitals in a tri-county area. This ED consists of 19 beds, five of
which are critical care beds, 12 acute care beds, and two psychiatric beds. This facility is a 222bed non-for-profit hospital primarily serving five counties consisting of 140,000 residents.
11

Congruence of Project to Selected Agency’s Mission, Values, and Goals
The mission of the institution where this project took place is “a commitment to helping
people live healthier through quality health care, trusting relationships, and providing value to
the people we serve” (Ephraim McDowell Health [EMH], 2021, paras. 1-3). Their goals include
“providing an environment filled with compassion, care and concern, recognition of each person
as a valued, unique individual, and adhering to principles that foster honesty, integrity,
confidence and safety” (EMH, 2021, paras. 1-3). This project’s intentions are in congruence
with this facility's mission and goals in terms of recognizing each person as valuable and
providing a compassionate environment/care regardless of patient presentation. This DNP
project seeks to recognize those suffering from SUD by screening them for substance use and
provide compassionate and holistic care and treatment options as well as break down the
stigmas associated with SUD and barriers to SUD treatment.
Description of Stakeholders
The stakeholders for this DNP project included ED patients, clinicians, and an
administrator. The patients represented the consumer and their main responsibility was to
participate in the NMASSIST screening. Patients may experience benefit in the form of SUD
screening and referral to treatment. Clinicians represented the professionals/healthcare
providers, and their responsibilities were to screen patients for SUD in the ED and implement
the NMASSIST screening if indicated. Clinicians may experience benefit due to increased
knowledge regarding SUD as well as an increased screening ability and comfortability. The role
of the administrator was represented by the ED director as she approved such project
implementation. She aided in monitoring the implementation of this project as well as
participating in such.
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Potential Facilitators and Barriers to Implementation
Facilitators of this project included the use of the NMASSIST tool which is a brief
screen for SUD. The screening itself takes no more than five-ten minutes to complete. There is a
strong need for the treatment of SUD, and this tool recommends treatment options for certain
scores of SUD, increasing the likelihood of treatment. The approval by the ED director was also
a facilitator for this DNP project, as well as the commitment of clinicians to participate over a
four-week timeframe. This project has the possibility of providing an appropriate and accessible
SUD screening tool for the ED, as there is not one currently in place.
There were barriers to the implementation of this project. The project was implemented
at a high volume ED. There may be time constraints, and this screening may not be completed
by clinicians due to lack of time and more emergent issues and prioritizing high acuity patients.
Patients may not have chosen to participate in the screening due to a possible fear of stigma
related to SUD.
Sample
Target Population, Inclusion and Exclusion Criteria
The target population for this project was ED clinicians and patients at Ephraim
McDowell Regional Medical Center. For this project, clinicians are defined as: registered nurses
(RN), physician assistants (PA), advanced practice registered nurse (APRN), and physicians
(MD). A convenience sample of 10 advanced practice providers/MD’s and 20 RN’s were
targeted for this project. Inclusion criteria include: 1) clinicians must be RN’S and/or advanced
practice providers/physicians, and 2) at least six months of ED experience. Exclusion criteria
are: 1) residential clinicians that are not board certified, 2) nursing students, and 3)
technicians/certified nursing assistants. Inclusion criteria intended for those involved in this
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project to be experienced clinicians at this facility. Exclusion criteria intended to exclude those
who are not certified clinicians or those not involved with interventional care and assessments.
Procedure
IRB Approval
This DNP project was approved by the University of Kentucky Institutional Review
Board on October 28, 2021 to assure protection of human subjects. The project involved
“minimal risk to the subjects not greater than one encounters in daily life” (University of
Kentucky Office of Research Integrity). To facilitate the approval, a letter of support was
obtained from the ED director demonstrating the organization’s support for the project.
Description of Evidence-based Intervention
The educational intervention, developed by the PI, consisted of a 20-minute educational
PowerPoint educating on SUD, the NMASSIST, and an ED patient scenario assessment guided
by the NMASSIST. This education module consisted of information regarding the prevalence as
well as factual information regarding SUD (see Appendix B). Participants were given four
weeks to complete the components of this project. The project procedures for this project were
the collection and analysis of data used to determine baseline education and post intervention
education regarding SUD.
Measures and Instruments
The PI created the instruments used in this DNP Project: 1) five-ten-minute pretest
electronic survey to collect baseline data, 2) five-ten-minute posttest electronic survey to
determine if there was an increase in knowledge of SUD, and 3) five-ten-minute satisfaction
survey to determine perceived satisfaction and impression of education delivery (see
Appendices C and D). The literature review showed an increase in perceived screening ability as
14

well as positive attitude improvements in a pilot study utilizing a one group pre/posttest design
and educational intervention based on SBIRT (Osborne & Benner, 2012). Qualtrics was utilized
to create the pretest, posttest, and satisfaction survey to administer to clinicians via their work
email. Each participant was asked to include their name and credentials in the pre/posttest so
that alterations in survey responses as can be traced before/after implementation of the education
module. This information was necessary to determine if the education module was effective in
enhancing SUD knowledge and screening practices. After completion of surveys, each
participant then received a number corresponding with their title (RN 1, RN 2, MD 1) to
determine education effectiveness in Qualtrics. Demographic characteristics were measured to
determine educational level (PA, APRN, MD, RN).
Clinician knowledge of SUD was based on six questions (answers presented in the
powerpoint education) assessed on a true/false scale, select the correct answer, and four choice
answer scenarios (A-D) (see Appendix C). A score of 70% or higher on the posttest was set by
the PI to indicate effectiveness of the education intervention in terms of knowledge of SUD.
Scoring for the pre/posttest was based on the number of correct questions answered (maximum
100%). Clinician screening frequency of SUD developed by the PI was based on one question
that asked “How frequently in the past two weeks did you screen for SUD among your patients”.
Comfortability with screening for SUD developed by the PI was based on one question that
asked “How comfortable do you feel screening patients for SUD”. A goal of 25% increase in
comfortability and frequency of screening for SUD post-intervention was set by the PI to
indicate effectiveness of the educational intervention. This goal was set due to it being attainable
and realistic, and will indicate a positive improvement. Previous knowledge/utilization of the
NMASSIST was assessed by asking participants “Have you heard of/utilized the NMASSIST”.
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A multiple choice question was asked to determine clinician knowledge of what the NMASSIST
represents in an A-D format question. Finally, an anonymous satisfaction survey with five
yes/no questions was used to assess the different parts of the educational intervention and
clinicians’ impression of the education delivery (see Appendix D).
Data Collection
All applicable clinicians were sent a cover letter containing detailed information
regarding the project inviting them to participate (see Appendix A). Participation in the project
implied consent. Clinicians were sent via email the cover letter, pretest, education module,
posttest, and satisfaction survey to determine clinician’s perceptions and effectiveness of the
educational module. A four-week timeframe was given to clinicians to complete the
components, and clinicians were sent weekly email reminders to complete all aspects. A total of
10 questions were utilized for the pre/posttest test, and a five question satisfaction survey via a
link generated by Qualtrics.
Data Analysis
Statistical package for the social sciences (SPSS, 2019) version 26 software was used to
analyze the data generated from this project. The analysis of knowledge of SUD was based on
the changes in the proportion of those who correctly answered 70% or higher on the knowledge
questions posttest. The differences in these proportions pre/posttest were analyzed using a paired
sample t-test. Clinicians’ were combined into groups (group one: APRN/PA, group two: MD,
group three: RN) to determine if baseline knowledge of SUD differed between the three groups
using a one-way ANOVA test. The analysis of clinicians’ screening for SUD was based on
changes in the mean scores on self-reported frequency of screening for SUD in the past two
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weeks using paired sample t-tests. The assessment of the satisfaction survey was based on
means and standard deviations (or frequencies and percentages).
Results
Demographics and Findings
There were 35 clinicians’ who met the inclusion criteria: 18 RN’s, five APRN’s, three
PA’s, and nine MD’s. Of the 35 clinicians’ invited to participate, 27 agreed to participate in this
project (15 RN’s, two APRN’s, two PA’s, and eight MD’s). RN’s accounted for 55.6%,
APRN’s 7.4%, PA’s 7.4%, and MD’s 29.6%. In total, 77.14% of clinicians’ invited to
participate completed the project. (See Table 1 for number of participants).
Completion of the pretest, posttest, and satisfaction survey was accomplished by 27
clinicians. To determine knowledge differences in the pre/posttest, a paired sample t-test was
utilized in SPSS. The total average score for the pretest was 52.43%. The total average score for
the posttest was 98.43%, 28.43% higher than projected scoring (goal was 70% as set by the PI),
indicating an 87% increase in knowledge (see Table 2 for average score pre/posttest). The pvalue was less than 0.001. Clinicians were then categorized into three groups to determine if
baseline knowledge of SUD differed based on education level using a ANOVA test (group one:
APRN/PA, group two: MD, group three: RN). APRN/PA were grouped together due to small
sample size (two PA’s/two APRN’s participated). Baseline knowledge did not differ by clinician
type (see Table 5).
Pretest, 7.4% of clinicians answered “never” to the question “how frequently in the past
two weeks did you screen for SUD among your patients”, 18.5% answered “seldom”, 33.3%
answered “occasionally”, and 40.7% answered “often” (see Table 6). Post-test, 0% answered
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“never”, 11.1% answered “seldom”, 33.3% answered “occasionally”, and 55.6% answered
“often”, an increase of nearly 37% (see Table 7).
Pretest, 7.4% of clinicians answered “not comfortable” to the question “how comfortable
do you feel screening patients for SUD”, 18.5% answered “somewhat comfortable”, 37%
answered “comfortable”, and 37% answered “very comfortable” (see Table 8). Posttest, 0%
answered “not comfortable”, 11.1% answered “somewhat comfortable”, 14.8% answered
“comfortable”, and 74.1% answered “very comfortable”, an increase of 100% (see Table 9).
Pre-education module, 7.4% answered “yes” to the question “have you heard of/utilized the
NMASSIST” (see Table 11). Post-education module, 77.8% answered “yes”, an increase of
800% (see Table 12).
In terms of the satisfaction survey, 100% of participants felt the information from the
education module was useful, that the NMASSIST could be utilized in the ED, felt this
education module increased their awareness of SUD, and would recommend this educational
module to clinicians (see Tables 14 and 15). Upon assessment, 66.7% of participants stated they
have utilized the NMASSIST in practice after the implementation of this education module.
Discussion
This project was able to accomplish its set aims, including: 1) the assessment of baseline
SUD knowledge and screening practices, 2) the evaluation of SUD knowledge and screening
practices post intervention, and 3) satisfaction of educational intervention. The results from this
DNP project supports the literature findings mentioned previously; there are significant
improvements in knowledge, attitudes, confidence and capability related to SUD treatment
utilizing SBIRT versus no education (Osborne & Benner, 2012). This project resulted in
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increased clinician knowledge and capability of screening those with SUD to allow them to be
treated/referred appropriately and holistically.
The prevalence of SUD in the U.S. is alarming, and many patient’s present to the ED due
to SUD. There is a gap in screening for SUD in ED’s, with a main aspect due to time
constraints, limited screening availability and knowledge amongst ED clinicians (Hawk &
D’Onofrio, 2018). The NMASSIST is an evidence-based tool recommended for clinician use to
not only determine adults at risk for/suffering from SUD but in guiding them to treatment
options/referrals. All participants from this project voted that the NMASSIST is a tool that can
be utilized in the ED.
There was an expected 25% increase of comfortability and frequency of screening for
SUD post intervention. Analysis of scoring resulted in a 100% increased rating of comfortability
and 37% increase of frequency of screening for SUD with a p-value less than 0.001, deeming
this intervention was statistically significant and surpassed initial expectations. All clinicians
(100%) in this study felt the NMASSIST could be utilized in an ED, demonstrating this is an
appropriate tool for the ED.
There is currently not a recommended tool for screening of SUD in the ED. The
NMASSIST has been utilized in an ED study successfully previously (Donovan et al., 2012).
The results of this project indicate the NMASSIST is an easy to use tool that can be utilized in
the ED setting. The project will have the potential to increase ED clinician knowledge, attitudes,
and awareness related to SUD and increase screening and referral rates for the treatment of SUD
in keeping with the Joint Commission standards. To support the sustainability of this project, the
educational module and the NMASSIST were printed and placed in the educational modules
section available for all ED clinicians to utilize.
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Implications
These research studies presented and the NMASSIST screening tool provide an
understanding on how we can more accurately and efficiently provide our patients with options
for SUD in the ED setting. The gaps related to SUD screening in the ED remain large, mainly
due to lack of screening tools/knowledge of screening tools, increased volume of patients,
unknown availability of screening tools, focused care, lack of time, high priority patients,
stigma, as well as lack of staff (Hawk & D’Onofrio, 2018).
In order for clinicians to provide the best level of care for patients, there should be
evidence-based practice guiding interventions for SUD in the ED. A tool such as the
NMASSIST should be implemented in the ED setting, easily located in charting systems for use.
Adding a screening tool to ED charting systems such as the NMASSIST that not only screens
patients for SUD but generates recommendations based on individualized scores is one simple
step ED’s can implement to address SUD.
More research is needed to increase the utilization of the NMASSIST tool and improve
SUD screening in general. Future research should be aimed to broaden training related to SUD
for clinicians with education modules, as well as studies implementing and assessing SUD
screening tools in charting systems.
Limitations
There were several limitations to this project. This project took place at a small rural ED,
therefore there was a small sample size of participants (N=27). This project was only
implemented in the ED of this hospital. A larger sample size may have been achieved if this
project was issued to all clinicians in the hospital. We are also in the midst of a global pandemic,
and this may have affected clinicians’/patients’ willingness to participate.
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Due to this project being implemented at a high volume ED, there may have been time
constraints. This screening may not be completed by clinicians due to more emergent issues and
prioritizing high acuity patients. Several clinicians may only chart what is required, and since
the NMASSIST is not required it may not be completed. There is also a privacy issue as several
rooms are conjoined, and patient’s may not want to disclose such information at risk of others
listening. Another limitation could be that the screening tool can only be completed on the web
rather than being integrated into the patient’s chart. Although frequency and comfortability with
SUD screening improved in this project, there is still a need for further research and feedback
from clinicians to determine how to address the gaps between SUD and the ED setting.
Conclusion
In summary, the aims of this DNP project were: 1) the assessment of baseline SUD
knowledge and screening practices, 2) the evaluation of SUD knowledge and screening practices
post intervention, and 3) satisfaction of educational intervention. The NMASSIST tool was
chosen to implement based on its validity and reliability, ease of usage, alerting clinicians to
acute and long-term effects of SUD as well as withdrawal symptoms, vulnerabilities in certain
SUD populations (including youth, older adults, and pregnant women), as well as treatment
recommendations and referral. It is well documented that SUD effects a substantial portion of
the U.S. population, and there is a lack of screening tools for such in the ED setting (Hawk &
D’Onofrio, 2018). This project demonstrated the NMASSIST is an effective SUD screening tool
that can be utilized in the ED.
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List of Tables
Data collection tables/results with demographics created in SPSS. APRN/PA were grouped
together due to sample size (two from each category) and are defined as APP.
Table 1
Number and Titles of Participants
Participant Title
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

APP

4

14.8

14.8

14.8

MD

8

29.6

29.6

44.4

RN

15

55.6

55.6

100.0

Total

27

100.0

100.0

Table 2
Average Scores of Pre/posttests
Paired Samples Statistics
Mean
Pair 1

N

Std. Deviation

Std. Error Mean

Score

3.6667

27

1.44115

.27735

Score

6.8889

27

.32026

.06163

Table 3
Paired Samples T-Test of Table 2
Paired Samples Test
Paired Differences
Mean
Pair 1

Score - Score

-3.22222

t

Std. Deviation
1.50214

26

One-Sided p
-11.146

26

<.001

Two-Sided p
<.001

Table 4
Comparison of pre-education and post-education knowledge scores (N = 27)

Knowledge score
(potential range 0-7)
Knowledge score
percentage

Pre-education
Mean (SD)
3.67 (1.44)

Post-education
Mean (SD)
6.89 (.32)

52.43%

98.43%

p
<.001

Table 5
Provider Type Baseline Knowledge Comparison.
ANOVA
Sum of Squares
Between Groups

df

Mean Square

3.525

2

1.762

Within Groups

50.475

24

2.103

Total

54.000

26

F

Sig.
.838

.445

Table 6
Frequency Screening of SUD Pre-education Module
How frequently in the past two weeks did you screen for SUD
among your patients?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Never

2

7.4

7.4

7.4

Seldom

5

18.5

18.5

25.9

Occasionally

9

33.3

33.3

59.3

Often

11

40.7

40.7

100.0

Total

27

100.0

100.0

27

Table 7
Frequency Screening of SUD Post-education Module
How frequently in the past two weeks did you screen for SUD
among your patients?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Seldom

3

11.1

11.1

11.1

Occasionally

9

33.3

33.3

44.4

Often

15

55.6

55.6

100.0

Total

27

100.0

100.0

Table 8
Comfortability of Screening for SUD Pre-education Module
How comfortable do you feel screening patients for SUD?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Not Comfortable

2

7.4

7.4

7.4

Somewhat Comfortable

5

18.5

18.5

25.9

Comfortable

10

37.0

37.0

63.0

Very Comfortable

10

37.0

37.0

100.0

Total

27

100.0

100.0

Table 9
Comfortability of Screening for SUD Post-education Module
How comfortable do you feel screening patients for SUD?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Somewhat Comfortable

3

11.1

11.1

11.1

Comfortable

4

14.8

14.8

25.9

Very Comfortable

20

74.1

74.1

100.0

Total

27

100.0

100.0

28

Table 10
Test Statistics for Frequency and Screening for SUD Pre and Post-education Module
Test Statisticsa

How frequently in the past two
weeks did you screen for SUD
among your patients? - How

How comfortable do you feel

frequently in the past two weeks

screening patients for SUD? -

did you screen for SUD among

How comfortable do you feel

your patients?

screening patients for SUD?

Z

-2.308b

-3.025b

.021

.002

Asymp. Sig. (2-tailed)
a. Wilcoxon Signed Ranks Test
b. Based on negative ranks.

Table 11
Utilization of the NMASSIST Pre-education Module
Have you heard of/utilized the Nida Modified Assist
(NMASSIST)?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Yes

2

7.4

7.4

7.4

No

25

92.6

92.6

100.0

Total

27

100.0

100.0
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Table 12
Utilization of the NMASSIST Post-education Module
Have you heard of/utilized the Nida Modified Assist
(NMASSIST)?
Cumulative
Frequency
Valid

Percent

Valid Percent

Percent

Yes

21

77.8

77.8

77.8

No

6

22.2

22.2

100.0

27

100.0

100.0

Total

Table 13
Chi-Square test for Utilization of the NMASSIST
Chi-Square Tests
Exact Sig. (2Value

sided)
<.001a

McNemar Test
N of Valid Cases

27

a. Binomial distribution used.
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Table 14
Frequency Table for Satisfaction Survey.
Do you feel this information was useful?
Frequency
Valid

Yes

Percent

27

Valid Percent

100.0

Cumulative Percent

100.0

100.0

Have you utilized the NMASSIST after learning about such tool?
Frequency
Valid

Percent

Valid Percent

Cumulative Percent

Yes

18

66.7

66.7

66.7

No

9

33.3

33.3

100.0

27

100.0

100.0

Total

Do you feel the NMASSIST is a tool that can be utilized in the ED?
Frequency
Valid

Yes

27

Percent

Valid Percent

100.0

Cumulative Percent

100.0

100.0

Do you feel this educational module increased your awareness of SUD?
Frequency
Valid

Yes

27

Percent

Valid Percent

100.0

Cumulative Percent

100.0

100.0

Would you recommend this educational module to clinicians?
Frequency
Valid

Yes

27

Percent

Valid Percent

100.0

100.0
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Cumulative Percent
100.0

Table 15
Summary of Satisfaction with Educational Module (N = 27).
Item
This information was useful
Have you utilized the NMASSIST
Can the NMASSIST be utilized in the ED
Did this education increase your awareness of SUD
Would you recommend this educational module
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Yes
n (%)
27 (100%)
18 (66.7%)
27 (100%)
27 (100%)
27 (100%)

List of Figures
Figure 1
NMASSIST Screen
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Figure 2
Scoring and Recommendations
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List of Appendices
Appendix A
Cover Letter.

To Research Participant:

Researchers at the University of Kentucky are inviting you to take part in a research study entitled “The
Effect of Education on the NIDA Modified Assist (NMASSIST) Tool on Knowledge and Screening for
Substance Use Disorder among Clinicians”. You are being asked to participate in the research study
because you are an advanced clinician/registered nurse in the Emergency Department at Ephraim
McDowell Regional Medical Center. This project consists of a fully online educational module and
surveys about substance use disorder (SUD). This project will consist of a pretest, educational module
regarding the NIDA Modified Assist (NMASSIST) SUD screening tool, posttest, and satisfaction survey
over the span of 30 days.
The purpose of this project is to evaluate clinician knowledge regarding SUD and screening ability in the
adult population in an acute ED setting. An educational module pertaining to SUD will be provided
which includes evidence and statistical information regarding SUD, as well as information to guide
clinicians in treatment options/referrals for the SUD population based on the education of the
NMASSIST. The specific aims of this project include: 1) the assessment of baseline SUD knowledge and
screening practices, 2) the evaluation of SUD knowledge and screening practices post intervention, and
3) satisfaction of educational intervention. By doing this study, we hope to learn baseline clinician
knowledge and screening practices before/after educational intervention. Your participation in this
research will last about 45 minutes to one hour over a 30-day span.
A pretest will be issued taking approximately 5-10 minutes. An educational module will be issued,
taking no more than 20 minutes to review. A posttest will be implemented taking no more than 5-10
minutes, along with a satisfaction survey, taking no more than 5-10 minutes. The total amount of time
you will be asked to volunteer for this study is 45 minutes to one hour over the course of 30 days.
Although you may not get personal benefit from taking part in this research study, your responses may
help us understand more about SUD. Some volunteers experience satisfaction from knowing they have
contributed to research that may possibly benefit others in the future.
If you do not want to be in the study, there are no other choices except not to take part in the study.
There are no known risks to participating in this study.
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Your identity will only be known by the primary investigator (Victoria Arnold). Your response to the
survey will be kept confidential to the extent allowed by the law. When we write about the study you
will not be identified.
Your information collected for this study will NOT be used or shared for future research studies, even if
we remove the identifiable information like your name, clinical record number, or date of birth.
We hope to receive completed questionnaires from about 30 people, so your answers are important to
us. Of course, you have a choice about whether or not to complete the survey/questionnaire, but if you
do participate, you are free to skip any questions or discontinue at any time. You will not be penalized
in any way for skipping or discontinuing the survey.
Please be aware, while we make every effort to safeguard your data once received from the online
survey company, given the nature of online surveys, as with anything involving the Internet, we can
never guarantee the confidentiality of the data while still on the survey company’s servers, or while en
route to either them or us. It is also possible the raw data collected for research purposes will be used
for marketing or reporting purposes by the survey/data gathering company after the research is
concluded, depending on the company’s Terms of Service and Privacy policies.

If you have questions about the study, please feel free to ask; my contact information is given below.
Thank you in advance for your assistance with this important project. To ensure your
responses/opinions will be included, please submit your completed survey/questionnaire by November
30, 2021. Prompts will be sent via email individually.
Sincerely,
Victoria Arnold, RN BSN
College of Nursing, University of Kentucky
PHONE: 859-805-1557
E-MAIL: victoria.arnold@uky.edu

Faculty Advisor: Evelyn Parrish, PhD, PHMNP-BC, FAANP
College of Nursing, University of Kentucky
E-MAIL: evelyn.parrish@uky.edu

If you have complaints, suggestions, or questions about your rights as a research volunteer, contact the
staff in the University of Kentucky Office of Research Integrity at 859-257-9428 or toll-free at 1-866400-9428.
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Appendix B
Educational module presented via powerpoint.
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Appendix C
NMASSIST pre/posttest issued to clinicians.
This test is designed to measure clinicians baseline and post intervention knowledge regarding
SUD. Please complete this five-minute pretest, then proceed to the educational module and
posttest. When submitting the pre/posttest, you are giving the primary investigator permission to
use such results for analyzation.
1) How prevalent is SUD in the U.S.?
A. 5%
B. 10%
C. 15%
D. 20%

2) How many deaths occur yearly due to overdoses in the U.S.?
A. 64,000
B. 22,000
C. 35,000
D. 50,000

3) What is the cost of SUD in the U.S.?
A. $98 Million
B. $970 Million
C. $150 Billion
D. $193 Billion
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4) Select the correct statement.
A. The number of overdoses caused by opioids has doubled since 1999.
B. The number of overdoses caused by opioids has quadrupled since 1999.
C. The number of overdoses caused by opioids has tripled since 1999.
D. The number of overdoses caused by opioids has decreased since 1999.

5) One in 20 individuals seen in an ED for a nonfatal overdose die within one year.
A. True.
B. False.

6) Since the year 2000, overdose deaths have increased by what percentage?
A. 58%
B. 105%
C. 137%
D. 190%

7) How frequently in the past two weeks did you screen for SUD among your patients?
0=Never

1=Seldom

2=Occasionally

3=Often

8) How comfortable do you feel screening patient’s for SUD?
0= Not comfortable 1=Somewhat comfortable

1=Comfortable

9) Have you heard of/utilized the Nida Modified Assist (NMASSIST)?
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2=Very comfortable

A. Yes
B. No

10) What is the NMASSIST?
A. An evidence-based screening tool developed to assist in the diagnosis of adult SUD
as well as offer treatment recommendations.
B. A tool to determine if someone has SUD.
C. An evidence-based tool to detect SUD in at risk youth.
D. A primary care tool to assist clinicians in determining who should begin rehabilitation
treatment for SUD.
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Appendix D
Satisfaction survey.
Please complete this satisfaction survey for the educational module.
1) Do you feel this information was useful?
Yes

No

2) Have you utilized the NMASSIST after learning about such tool?
Yes

No

3) Do you feel the NMASSIST is a tool that can be utilized in the ED?
Yes

No

4) Do you feel this educational module increased your awareness of SUD?
Yes

No

5) Would you recommend this educational module to clinicians?
Yes

No
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